Thursday Jul 24
Medivation Announces Second Quarter 2014 Financial Results Teleconference on August 7, 2014
Medivation, Inc. today announced that it will host a live teleconference with management to discuss second quarter 2014 financial results and provide a general business update on August 7, 2014 at 4:30 p.m. Eastern Time.
Medivation Significantly Undervalued, With Xtandi Weeks Away From Prostate Cancer Label Expansion
With overwhelming efficacy results from the PREVAIL Phase III trial, acceptance is a foregone conclusion that is not yet fully built into the price of the stock.
Medivation Receives Consensus Rating of "Buy" from Brokerages
Shares of Medivation have received a consensus recommendation of "Buy" from the twenty analysts that are covering the company, Analyst Ratings Network reports .
Medivation Announces Change in Executive Management Team
Ms. Svoronos currently is a member of Medivation's Board of Directors and is a former president of Europe and Canada for Merck & Co.
Insider Selling: Lynn Seely Unloads 12,000 Shares of Medivation Stock
Medivation Insider Lynn Seely sold 12,000 shares of the stock in a transaction that occurred on Wednesday, July 2nd.
The Motley Fool
3 Reasons to Buy Medivation Inc.
The biotech industry has ballooned in terms of market value over the past two years.
MEDIVATION, INC. FILES (8-K) Disclosing Change in Directors or...
MEDIVATION, INC. FILES Disclosing Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits Item 5.02.